Adult-Onset Still Disease as a Novel Autoimmune Complication of Alemtuzumab Therapy: A Case Report and Review of Alemtuzumab-Associated Autoimmune Disease

J Clin Rheumatol. 2021 Dec 1;27(8S):S411-S413. doi: 10.1097/RHU.0000000000001382.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alemtuzumab / adverse effects
  • Autoimmune Diseases* / chemically induced
  • Autoimmune Diseases* / diagnosis
  • Humans
  • Still's Disease, Adult-Onset* / diagnosis
  • Still's Disease, Adult-Onset* / drug therapy

Substances

  • Alemtuzumab